Ozempic Impurities Explained: Ensuring Purity and Safety in Semaglutide-Based Therapies
Semaglutide has emerged as a groundbreaking therapy for managing type 2 diabetes, marketed under brand names like...
AMSbiopharma, Sponsor of the XIX Iberian Peptides Meeting (EPI 2025)
We are pleased to announce that AMSbiopharma will be an official sponsor of the XIX Iberian Peptides Meeting...
Peptide Drugs: Discovery and Development Explained
What Are Peptide Drugs and How Are They Used in Therapeutics? Peptide drugs, also known as therapeutic peptides,...
Application of Hydrophilic Interaction Chromatography (HILIC) in pharmaceutical analysis
Analyzing polar compounds via high-performance liquid chromatography (HPLC) has long posed a challenge due to their limited retention...
How to Manage Nitrosamine Contamination in Active Pharmaceutical Ingredients
In 2018, the detection of nitrosamines in sartan-type drugs, medications to treat high blood pressure and heart failure,...
AMSbiopharma launches an Innovation Plan to strengthen its position in the biopharmaceutical analytical services sector
AMSbiopharma, a CRO (Contract Research Organization) belonging to AMSlab Group and specialized in advanced analytical services for the...
New update for the ICH Q2 (R2) guidance on Analytical Process Validation
As planned for months, the draft ICH Q14 Guideline for AQbD Method Development and the draft ICH Q2...
AMSbiopharma and LEF announce strategic partnership to expand service offering
AMSbiopharma is pleased to announce a new strategic partnership with LEF, a CRO and CDMO based in Portugal...